Literature DB >> 17012052

Phyllodes breast tumour showing invasive squamous-cell carcinoma with invasive ductal, clear-cell, secretory, and squamous components.

Michael J Ramdass1, Shiva Dindyal.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17012052     DOI: 10.1016/S1470-2045(06)70909-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

1.  Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ: case report and review of the literature.

Authors:  Mardiana Abdul Aziz; Frank Sullivan; Michael J Kerin; Grace Callagy
Journal:  Patholog Res Int       Date:  2010-07-05

Review 2.  Ductal carcinoma in-situ arising within benign phyllodes tumours.

Authors:  S-A Lui; H B Oh; S Wang; C W Chan
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

3.  Ductal carcinoma in situ arising within a benign phyllodes tumor: A case report with a review of the literature.

Authors:  Yoshinori Nio; Chikage Iguchi; Kazuhiko Tsuboi; Riruke Maruyama
Journal:  Oncol Lett       Date:  2010-12-08       Impact factor: 2.967

4.  Invasive cribriform carcinoma arising in malignant phyllodes tumor of breast: a case report.

Authors:  Yoomi Choi; Kyoung Yul Lee; Min Hye Jang; Hyesil Seol; Sung-Won Kim; So Yeon Park
Journal:  Korean J Pathol       Date:  2012-04-25

5.  Invasive ductal carcinoma within borderline phyllodes tumor with lymph node metastases: A case report and review of the literature.

Authors:  D I Wu; Haipeng Zhang; Liang Guo; X U Yan; Zhimin Fan
Journal:  Oncol Lett       Date:  2016-02-17       Impact factor: 2.967

Review 6.  Collision tumor with inflammatory breast carcinoma and malignant phyllodes tumor: a case report and literature review.

Authors:  Young Duck Shin; Seul Kee Lee; Kyu Sun Kim; Mi Ja Park; Joo Heon Kim; Hyun Sun Yim; Young Jin Choi
Journal:  World J Surg Oncol       Date:  2014-01-08       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.